NLRC3
Basic information
Region (hg38): 16:3539033-3577403
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 94 | 12 | 109 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 94 | 15 | 4 |
Variants in NLRC3
This is a list of pathogenic ClinVar variants found in the NLRC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-3541823-G-A | not provided (-) | |||
16-3541886-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
16-3542215-C-T | not specified | Uncertain significance (Dec 09, 2024) | ||
16-3542959-C-A | not provided (-) | |||
16-3543426-C-T | not provided (-) | |||
16-3544289-C-T | not specified | Uncertain significance (Feb 07, 2025) | ||
16-3544314-G-A | not provided (-) | |||
16-3544380-T-C | not provided (-) | |||
16-3548149-G-A | not provided (-) | |||
16-3548189-G-A | not provided (-) | |||
16-3548190-C-T | Likely benign (Feb 01, 2025) | |||
16-3548584-G-C | not provided (-) | |||
16-3548727-T-G | not provided (-) | |||
16-3549162-G-C | not provided (-) | |||
16-3549219-T-C | not provided (-) | |||
16-3550427-G-C | not specified | Uncertain significance (Feb 14, 2023) | ||
16-3552260-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
16-3554270-C-T | not specified | Uncertain significance (Oct 29, 2024) | ||
16-3554279-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
16-3554290-C-G | not specified | Uncertain significance (Nov 12, 2021) | ||
16-3554318-C-T | not specified | Likely benign (Feb 13, 2023) | ||
16-3554573-A-C | not provided (-) | |||
16-3554618-C-G | not provided (-) | |||
16-3556537-C-G | not provided (-) | |||
16-3556662-G-A | not provided (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NLRC3 | polymorphic_pseudogene | protein_coding | ENST00000448023 | 19 | 38369 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.23e-25 | 0.000749 | 124411 | 2 | 238 | 124651 | 0.000963 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.494 | 705 | 669 | 1.05 | 0.0000425 | 7053 |
Missense in Polyphen | 137 | 130.91 | 1.0465 | 1573 | ||
Synonymous | -1.24 | 339 | 311 | 1.09 | 0.0000221 | 2351 |
Loss of Function | 0.288 | 39 | 41.0 | 0.951 | 0.00000190 | 470 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00379 | 0.00378 |
Ashkenazi Jewish | 0.0000997 | 0.0000994 |
East Asian | 0.000473 | 0.000445 |
Finnish | 0.000432 | 0.000418 |
European (Non-Finnish) | 0.000567 | 0.000549 |
Middle Eastern | 0.000473 | 0.000445 |
South Asian | 0.00121 | 0.00114 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Negative regulator of the innate immune response (PubMed:15705585, PubMed:22863753, PubMed:25277106). Attenuates signaling pathways activated by Toll-like receptors (TLRs) and the DNA sensor STING/TMEM173 in response to pathogen-associated molecular patterns, such as intracellular poly(dA:dT), but not poly(I:C), or in response to DNA virus infection, including that of Herpes simplex virus 1 (HSV1) (By similarity) (PubMed:22863753). May affect TLR4 signaling by acting at the level of TRAF6 ubiquitination, decreasing the activating 'Lys-63'- linked ubiquitination and leaving unchanged the degradative 'Lys- 48'-linked ubiquitination (PubMed:22863753). Inhibits the PI3K- AKT-mTOR pathway possibly by directly interacting with the posphatidylinositol 3-kinase regulatory subunit p85 (PIK3R1/PIK3R2) and disrupting the association between PIK3R1/PIK3R2 and the catalytic subunit p110 (PIK3CA/PIK3CB/PIK3CD) and reducing PIK3R1/PIK3R2 activation. Via its regulation of the PI3K-AKT-mTOR pathway, controls cell proliferation, predominantly in intestinal epithelial cells (By similarity). May also affect NOD1- or NOD2-mediated NF-kappa-B activation (PubMed:25277106). Might also affect the inflammatory response by preventing NLRP3 inflammasome formation, CASP1 cleavage and IL1B maturation (PubMed:25277106). {ECO:0000250|UniProtKB:Q5DU56, ECO:0000269|PubMed:15705585, ECO:0000269|PubMed:22863753, ECO:0000269|PubMed:25277106}.;
- Pathway
- STING mediated induction of host immune responses;Innate Immune System;Immune System;IRF3-mediated induction of type I IFN;Cytosolic sensors of pathogen-associated DNA
(Consensus)
Recessive Scores
- pRec
- 0.112
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.251
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Nlrc3
- Phenotype
- hematopoietic system phenotype; immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- I-kappaB kinase/NF-kappaB signaling;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of NF-kappaB transcription factor activity;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of interleukin-6 production;negative regulation of tumor necrosis factor production;intracellular signal transduction;T cell activation;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of innate immune response;negative regulation of fibroblast proliferation;negative regulation of epithelial cell proliferation;negative regulation of inflammatory response;negative regulation of cytokine production involved in inflammatory response;negative regulation of NLRP3 inflammasome complex assembly;negative regulation of NIK/NF-kappaB signaling
- Cellular component
- cytoplasm;microtubule organizing center;cytosol;perinuclear region of cytoplasm
- Molecular function
- molecular_function;protein binding;ATP binding;phosphatidylinositol 3-kinase regulatory subunit binding